February 5, 2025
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 strategy, will be well-positioned as a scaled, pure-play MedTech leader focused on attractive categories shaping the future of health care Biosciences and Diagnostic Solutions to realize its full market [...]
Sapio Sciences Selected by LabConnect to Transform Laboratory Operations
February 4, 2025
Sapio LIMS to enhance research workflows, improve data integrity, and support scalable innovation Baltimore, MD, 04 February 2025 – Sapio Sciences, the science-aware™ lab informatics platform, today announced that LabConnect, a global leader in central laboratory services, has chosen Sapio LIMS (Laboratory Information Management System) to digitally transform complex research workflows, streamline sample tracking, and enhance data management. [...]
Optibrium Widens Access to Industry-Leading Docking Method
February 4, 2025
New PyMOL interface extends access to Optibrium’s structure-based design method Surflex-Dock CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design today announced the introduction of a new PyMOL Graphical User Interface (GUI) for Surflex-Dock, its industry-leading structure-based design method, which is part of the company’s BioPharmics 3D molecular modelling suite. [...]
February 4, 2025
Offers increased versatility and data-driven insights with 43% greater motor stroke range (100 mm),1 expanding testing to more materials across diverse industries. Improved dynamic performance completes fatigue testing up to 30% faster than the competition,2 increasing the speed of product development and validation. Designed to simplify testing workflows, with automated controls and fewer process steps to [...]
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
February 4, 2025
BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the formation of its Scientific Advisory Board. Comprised of distinguished experts in proteomics, genomics, bioinformatics, chemistry, and engineering, the board will play a critical role in shaping Quantum-Si’s scientific and development strategy, identifying emerging trends and applications, and strengthening engagement within [...]
Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
February 4, 2025
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D. to serve as an independent director on the Company's Board of Directors beginning on February 1, 2025. Dr. Herr will serve on the Science & Technology Committee of the Board of Directors. Dr. Herr is a Chancellor's Professor of Bioengineering at the [...]
CN Bio launches PhysioMimix DILI assay kit: Human 24, for enhanced preclinical toxicology testing
February 4, 2025
All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection 24 replicates to support simultaneous assessment of up to eight conditions per kit Cambridge, UK: CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate [...]
Pluristyx Announces Filing of Drug Master File for PluriBank™ iPSC Lines with U.S. FDA
February 4, 2025
Streamlined regulatory documentation accelerates development of next generation therapies SEATTLE -- Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its PluriBank™ CG (Clinical Grade) iPSC lines. This comprehensive regulatory submission details [...]
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
February 4, 2025
Decision Marks a Significant Legal Victory for Parse Biosciences, Reinforcing Commitment to Innovation and Fair Competition SEATTLE -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued Final Written Decisions invalidating [...]
Promega PowerPlex® 35GY System, First 8-Color STR Kit, Approved for NDIS by FBI
February 4, 2025
PowerPlex® 35GY System is the first commercially available 8-color STR kit for forensic DNA analysis Approval indicates the kit is suitable for generating profiles to be uploaded into the National DNA Index System MADISON, Wis. -- PowerPlex® 35GY System, the first 8-color STR analysis chemistry, has been approved by the FBI for use in the [...]

